Literature DB >> 19445741

Recurrent cystitis in non-pregnant women.

Ayan Sen1.   

Abstract

INTRODUCTION: Cystitis is a bacterial infection of the lower urinary tract which causes pain when passing urine, and causes urgency, haematuria, and suprapubic pain not associated with passing urine. Recurrent cystitis is usually defined as three episodes of urinary tract infection in the previous 12 months, or two episodes in the previous 6 months. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical question: Which interventions prevent further recurrence of cystitis in women experiencing at least two infections per year? We searched: Medline, Embase, The Cochrane Library, and other important databases up to April 2007 (BMJ Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found 14 systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: continuous antibiotic prophylaxis (trimethoprim, co-trimoxazole, nitrofurantoin, cefaclor, or a quinolone or cephalexin); continuous prophylaxis with methenamine hippurate; cranberry juice and cranberry products; oestrogen (topical) in postmenopausal women; passing urine after intercourse; postcoital antibiotic prophylaxis; single-dose self-administered antibiotic.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19445741      PMCID: PMC2907990     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  19 in total

1.  Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infections.

Authors:  T M Hooton; A E Stapleton; P L Roberts; C Winter; D Scholes; T Bavendam; W E Stamm
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

2.  Treatment of uncomplicated urinary tract infection in non-pregnant women.

Authors:  C E Mabeck
Journal:  Postgrad Med J       Date:  1972-02       Impact factor: 2.401

3.  [Frequent cystitis in elderly women. A double-blind comparison of Hiprex and placebo in general practice].

Authors:  R Gundersen; H O Høivik; K Osmundsen
Journal:  Tidsskr Nor Laegeforen       Date:  1986-09-10

4.  [Prevention of recurrent cystitis in fertile women. A double-blind comparison of Hiprex and placebo in general practice].

Authors:  H O Høivik; R Gundersen; K Osmundsen; P Halvorsen; P Hjortdahl; J G Stokke
Journal:  Tidsskr Nor Laegeforen       Date:  1984-06-10

Review 5.  Recurrent urinary tract infection in women.

Authors:  T M Hooton
Journal:  Int J Antimicrob Agents       Date:  2001-04       Impact factor: 5.283

6.  [Prevention and treatment of recurrent urinary system infection with estrogen cream in postmenopausal women].

Authors:  R Xu; Y Wu; Y Hu
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2001-09

7.  Secondary prevention of recurrent urinary tract infections. Comparison of the effect of placebo, methenamine hippurate, nitrofurantoin and trimethoprim alone.

Authors:  A Kasanen; S Y Junnila; E Kaarsalo; A Hajba; H Sundquist
Journal:  Scand J Infect Dis       Date:  1982

8.  Management of recurrent urinary tract infections with patient-administered single-dose therapy.

Authors:  E S Wong; M McKevitt; K Running; G W Counts; M Turck; W E Stamm
Journal:  Ann Intern Med       Date:  1985-03       Impact factor: 25.391

9.  Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women.

Authors:  R Raz; R Colodner; Y Rohana; S Battino; E Rottensterich; I Wasser; W Stamm
Journal:  Clin Infect Dis       Date:  2003-05-21       Impact factor: 9.079

10.  Recurring urinary tract infection: incidence and risk factors.

Authors:  B Foxman
Journal:  Am J Public Health       Date:  1990-03       Impact factor: 9.308

View more
  6 in total

1.  Guidelines for the diagnosis and management of recurrent urinary tract infection in women.

Authors:  Shawn Dason; Jeyapandy T Dason; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

Review 2.  Applications of Polymers for Organ-on-Chip Technology in Urology.

Authors:  Bianca Galateanu; Ariana Hudita; Elena Iuliana Biru; Horia Iovu; Catalin Zaharia; Eliza Simsensohn; Marieta Costache; Razvan-Cosmin Petca; Viorel Jinga
Journal:  Polymers (Basel)       Date:  2022-04-20       Impact factor: 4.967

3.  An economic perspective on urinary tract infection: the "costs of resignation".

Authors:  Oriana Ciani; Daniele Grassi; Rosanna Tarricone
Journal:  Clin Drug Investig       Date:  2013-04       Impact factor: 2.859

4.  Pharmacokinetics, Safety, and Clinical Outcomes of Omadacycline in Women with Cystitis: Results from a Phase 1b Study.

Authors:  J Scott Overcash; Pouru Bhiwandi; Lynne Garrity-Ryan; Judith Steenbergen; Stephen Bai; Surya Chitra; Amy Manley; Evan Tzanis
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

5.  Cysticlean® a highly pac standardized content in the prevention of recurrent urinary tract infections: an observational, prospective cohort study.

Authors:  Francisco Sánchez Ballester; Vicente Ruiz Vidal; Emilio López Alcina; Cristina Domenech Perez; Eva Escudero Fontano; Ana Oltra Benavent; Ana Montoliu García; Marco Sobrón Bustamante
Journal:  BMC Urol       Date:  2013-06-05       Impact factor: 2.264

6.  Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulfate (CS) for the treatment of female recurrent urinary tract infections: a European multicentre nested case-control study.

Authors:  Oriana Ciani; Erik Arendsen; Martin Romancik; Richard Lunik; Elisabetta Costantini; Manuel Di Biase; Giuseppe Morgia; Eugenia Fragalà; Tomaskin Roman; Marian Bernat; Giorgio Guazzoni; Rosanna Tarricone; Massimo Lazzeri
Journal:  BMJ Open       Date:  2016-03-31       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.